You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 11, November 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on ISI (3)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Alzheimer Disease
 •Dementias
 •Neurology, Other
 •Nutritional and Metabolic Disorders
 •Lipids and Lipid Disorders
 •Alert me on articles by topic

Docosahexaenoic Acid and Alzheimer Disease

Arch Neurol. 2006;63:1527-1528.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The study by Schaefer et al in this issue of Archives of Neurology1 is an important contribution to a young field of study on diet and neurodegenerative diseases. The authors found lower 9-year risk of incident Alzheimer disease among persons with higher levels of plasma phosphatidylcholine docosahexaenoic acid (DHA). The association was specific to DHA as none of the other {omega}-3 fatty acids was associated with Alzheimer disease risk. In a subset of their cohort, fish consumption was positively correlated with plasma DHA but was not statistically significantly associated with incident Alzheimer disease. However, it is possible that the analysis was underpowered to observe a protective association of fish consumption, as the inverse relative risk was based on a relatively small subsample of 488 subjects.

As one of the {omega}-3 fatty acids, an essential class of nutrients that cannot be synthesized endogenously by mammalians, DHA must be obtained through diet. . . . [Full Text of this Article]

AUTHOR INFORMATION

Martha Clare Morris, ScD


RELATED ARTICLE

Plasma Phosphatidylcholine Docosahexaenoic Acid Content and Risk of Dementia and Alzheimer Disease: The Framingham Heart Study
Ernst J. Schaefer, Vanina Bongard, Alexa S. Beiser, Stefania Lamon-Fava, Sander J. Robins, Rhoda Au, Katherine L. Tucker, David J. Kyle, Peter W. F. Wilson, and Philip A. Wolf
Arch Neurol. 2006;63(11):1545-1550.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.